ID   EI2BD_HUMAN             Reviewed;         523 AA.
AC   Q9UI10; Q53RY7; Q5BJF4; Q9BUV9; Q9UBG4; Q9UIQ9; Q9UJ95;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   12-FEB-2003, sequence version 2.
DT   18-JUN-2025, entry version 202.
DE   RecName: Full=Translation initiation factor eIF2B subunit delta;
DE   AltName: Full=eIF2B GDP-GTP exchange factor subunit delta;
GN   Name=EIF2B4; Synonyms=EIF2BD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H., Gu B.-W.,
RA   Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J., Xu S.-H., Gu J.,
RA   Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M., Huang G.-Y., Chen Z.,
RA   Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal axis
RT   and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3).
RA   Wightman P.J., Bonthron D.T.;
RT   "cDNA cloning, genomic organization and chromosomal localization of the
RT   human eIF2B delta subunit.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-86, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-86, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-86, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-86 AND SER-130, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=28169297; DOI=10.1038/ncomms13876;
RA   Wang L., Fu B., Li W., Patil G., Liu L., Dorf M.E., Li S.;
RT   "Comparative influenza protein interactomes identify the role of
RT   plakophilin 2 in virus restriction.";
RL   Nat. Commun. 8:13876-13876(2017).
RN   [16]
RP   FUNCTION, ACTIVITY REGULATION, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   IDENTIFICATION IN THE EIF2B COMPLEX.
RX   PubMed=25858979; DOI=10.1126/science.aaa6986;
RA   Sekine Y., Zyryanova A., Crespillo-Casado A., Fischer P.M., Harding H.P.,
RA   Ron D.;
RT   "Stress responses. Mutations in a translation initiation factor identify
RT   the target of a memory-enhancing compound.";
RL   Science 348:1027-1030(2015).
RN   [17]
RP   FUNCTION, AND IDENTIFICATION IN THE EIF2B COMPLEX.
RX   PubMed=27023709; DOI=10.1007/s10969-016-9203-3;
RA   Kashiwagi K., Shigeta T., Imataka H., Ito T., Yokoyama S.;
RT   "Expression, purification, and crystallization of Schizosaccharomyces pombe
RT   eIF2B.";
RL   J. Struct. Funct. Genomics 17:33-38(2016).
RN   [18] {ECO:0007744|PDB:6K71, ECO:0007744|PDB:6K72}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.30 ANGSTROMS) IN COMPLEX WITH THE EIF2
RP   COMPLEX, FUNCTION, SUBUNIT, AND IDENTIFICATION IN THE EIF2B COMPLEX.
RX   PubMed=31048492; DOI=10.1126/science.aaw4104;
RA   Kashiwagi K., Yokoyama T., Nishimoto M., Takahashi M., Sakamoto A.,
RA   Yonemochi M., Shirouzu M., Ito T.;
RT   "Structural basis for eIF2B inhibition in integrated stress response.";
RL   Science 364:495-499(2019).
RN   [19]
RP   VARIANTS VWM4 VAL-228; GLN-357 AND CYS-374, AND VARIANT GLY-306.
RX   PubMed=11835386; DOI=10.1002/ana.10112;
RA   van der Knaap M.S., Leegwater P.A.J., Koenst A.A.M., Visser A., Naidu S.,
RA   Oudejans C.B.M., Schutgens R.B.H., Pronk J.C.;
RT   "Mutations in each of the five subunits of translation initiation factor
RT   eIF2B can cause leukoencephalopathy with vanishing white matter.";
RL   Ann. Neurol. 51:264-270(2002).
RN   [20]
RP   VARIANTS VWM4 ARG-465 AND HIS-489.
RX   PubMed=12707859; DOI=10.1086/375404;
RA   Fogli A., Rodriguez D., Eymard-Pierre E., Bouhour F., Labauge P.,
RA   Meaney B.F., Zeesman S., Kaneski C.R., Schiffmann R., Boespflug-Tanguy O.;
RT   "Ovarian failure related to eukaryotic initiation factor 2B mutations.";
RL   Am. J. Hum. Genet. 72:1544-1550(2003).
RN   [21]
RP   VARIANTS VWM4 GLN-209; ARG-269 AND CYS-374.
RX   PubMed=15776425; DOI=10.1002/humu.9325;
RA   Ohlenbusch A., Henneke M., Brockmann K., Goerg M., Hanefeld F.,
RA   Kohlschutter A., Gartner J.;
RT   "Identification of ten novel mutations in patients with eIF2B-related
RT   disorders.";
RL   Hum. Mutat. 25:411-411(2005).
CC   -!- FUNCTION: Acts as a component of the translation initiation factor 2B
CC       (eIF2B) complex, which catalyzes the exchange of GDP for GTP on
CC       eukaryotic initiation factor 2 (eIF2) gamma subunit (PubMed:25858979,
CC       PubMed:27023709, PubMed:31048492). Its guanine nucleotide exchange
CC       factor activity is repressed when bound to eIF2 complex phosphorylated
CC       on the alpha subunit, thereby limiting the amount of methionyl-
CC       initiator methionine tRNA available to the ribosome and consequently
CC       global translation is repressed (PubMed:25858979, PubMed:31048492).
CC       {ECO:0000269|PubMed:25858979, ECO:0000269|PubMed:27023709,
CC       ECO:0000269|PubMed:31048492}.
CC   -!- ACTIVITY REGULATION: Activated by the chemical integrated stress
CC       response (ISR) inhibitor ISRIB which stimulates guanine nucleotide
CC       exchange factor activity for both phosphorylated and unphosphorylated
CC       eIF2. {ECO:0000269|PubMed:25858979}.
CC   -!- SUBUNIT: Component of the translation initiation factor 2B (eIF2B)
CC       complex which is a heterodecamer of two sets of five different
CC       subunits: alpha, beta, gamma, delta and epsilon. Subunits alpha, beta
CC       and delta comprise a regulatory subcomplex and subunits epsilon and
CC       gamma comprise a catalytic subcomplex (PubMed:25858979,
CC       PubMed:27023709, PubMed:31048492). Within the complex, the hexameric
CC       regulatory complex resides at the center, with the two heterodimeric
CC       catalytic subcomplexes bound on opposite sides (PubMed:31048492).
CC       {ECO:0000269|PubMed:25858979, ECO:0000269|PubMed:27023709,
CC       ECO:0000269|PubMed:31048492}.
CC   -!- INTERACTION:
CC       Q9UI10; P01019: AGT; NbExp=3; IntAct=EBI-2340132, EBI-751728;
CC       Q9UI10; P49770: EIF2B2; NbExp=9; IntAct=EBI-2340132, EBI-718773;
CC       Q9UI10; Q53XC2: EIF2B2; NbExp=4; IntAct=EBI-2340132, EBI-10288660;
CC       Q9UI10; P01100: FOS; NbExp=3; IntAct=EBI-2340132, EBI-852851;
CC       Q9UI10; P50440: GATM; NbExp=3; IntAct=EBI-2340132, EBI-2552594;
CC       Q9UI10; P62993: GRB2; NbExp=3; IntAct=EBI-2340132, EBI-401755;
CC       Q9UI10; P03952: KLKB1; NbExp=3; IntAct=EBI-2340132, EBI-10087153;
CC       Q9UI10; P06858: LPL; NbExp=3; IntAct=EBI-2340132, EBI-715909;
CC       Q9UI10; P31930: UQCRC1; NbExp=3; IntAct=EBI-2340132, EBI-1052596;
CC       Q9UI10; P40337-2: VHL; NbExp=3; IntAct=EBI-2340132, EBI-12157263;
CC       Q9UI10; P06821: M; Xeno; NbExp=3; IntAct=EBI-2340132, EBI-2547404;
CC       Q9UI10; Q6DPW5: M; Xeno; NbExp=2; IntAct=EBI-2340132, EBI-12562156;
CC       Q9UI10; C5E519: M2; Xeno; NbExp=2; IntAct=EBI-2340132, EBI-12562139;
CC       Q9UI10; Q20MH8: M2; Xeno; NbExp=3; IntAct=EBI-2340132, EBI-12576433;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q09924}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UI10-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UI10-2; Sequence=VSP_001433, VSP_040130;
CC       Name=3;
CC         IsoId=Q9UI10-3; Sequence=VSP_040130;
CC   -!- DISEASE: Leukoencephalopathy with vanishing white matter 4 (VWM4)
CC       [MIM:620314]: An autosomal recessive brain disease characterized by
CC       neurological features including progressive cerebellar ataxia,
CC       spasticity, and cognitive deficits. Brain imaging shows abnormal white
CC       matter that vanishes over time and is replaced by cerebrospinal fluid.
CC       Disease severity ranges from fatal infantile forms to adult forms
CC       without neurological deterioration. The disease is progressive with, in
CC       most individuals, additional episodes of rapid deterioration following
CC       febrile infections or minor head trauma. Death may occurs after a
CC       variable period after disease onset, usually following an episode of
CC       fever and coma. A subset of affected females with milder forms of the
CC       disease who survive to adolescence exhibit ovarian dysfunction. This
CC       variant of the disorder is called ovarioleukodystrophy.
CC       {ECO:0000269|PubMed:11835386, ECO:0000269|PubMed:12707859,
CC       ECO:0000269|PubMed:15776425}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the eIF-2B alpha/beta/delta subunits family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB57305.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mendelian genes eukaryotic translation initiation
CC       factor 2B, subunit 4 delta, 67kDa (EIF2B4); Note=Leiden Open Variation
CC       Database (LOVD);
CC       URL="https://databases.lovd.nl/shared/genes/EIF2B4";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF112207; AAF17195.1; -; mRNA.
DR   EMBL; AJ011305; CAB57260.1; -; mRNA.
DR   EMBL; AJ011306; CAB57261.1; -; mRNA.
DR   EMBL; AJ011307; CAB57304.1; -; Genomic_DNA.
DR   EMBL; AJ011308; CAB57304.1; JOINED; Genomic_DNA.
DR   EMBL; AJ011307; CAB57305.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AJ011308; CAB57305.1; JOINED; Genomic_DNA.
DR   EMBL; AC074117; AAY14843.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00591.1; -; Genomic_DNA.
DR   EMBL; BC001870; AAH01870.1; -; mRNA.
DR   EMBL; BC091502; AAH91502.1; -; mRNA.
DR   CCDS; CCDS33164.1; -. [Q9UI10-1]
DR   CCDS; CCDS46244.1; -. [Q9UI10-3]
DR   CCDS; CCDS46245.1; -. [Q9UI10-2]
DR   RefSeq; NP_001029288.1; NM_001034116.2. [Q9UI10-1]
DR   RefSeq; NP_001305894.1; NM_001318965.1.
DR   RefSeq; NP_001305895.1; NM_001318966.1.
DR   RefSeq; NP_001305896.1; NM_001318967.1.
DR   RefSeq; NP_001305897.1; NM_001318968.1.
DR   RefSeq; NP_056451.3; NM_015636.3. [Q9UI10-3]
DR   RefSeq; NP_751945.2; NM_172195.4. [Q9UI10-2]
DR   PDB; 6CAJ; EM; 2.80 A; E/F=1-523.
DR   PDB; 6EZO; EM; 4.10 A; G/H=1-523.
DR   PDB; 6K71; EM; 4.30 A; G/H=1-523.
DR   PDB; 6K72; EM; 4.60 A; G/H=1-523.
DR   PDB; 6O81; EM; 3.21 A; E/F=1-523.
DR   PDB; 6O85; EM; 3.03 A; E/F=1-523.
DR   PDB; 6O9Z; EM; 3.03 A; E/F=1-523.
DR   PDB; 7D43; EM; 4.30 A; G/H=1-523.
DR   PDB; 7D44; EM; 4.00 A; G/H=1-523.
DR   PDB; 7D45; EM; 3.80 A; G/H=1-523.
DR   PDB; 7D46; EM; 4.00 A; G/H=1-523.
DR   PDB; 7F64; EM; 2.42 A; G/H=1-523.
DR   PDB; 7F66; EM; 2.76 A; G/H=1-523.
DR   PDB; 7F67; EM; 3.59 A; G/H=1-523.
DR   PDB; 7KMF; EM; 2.91 A; E/F=1-523.
DR   PDB; 7L70; EM; 2.80 A; E/F=1-523.
DR   PDB; 7L7G; EM; 3.00 A; E/F=1-523.
DR   PDB; 7RLO; EM; 2.60 A; E/F=1-523.
DR   PDB; 7TRJ; EM; 2.80 A; E/F=1-523.
DR   PDB; 7VLK; EM; 2.27 A; G/H=1-523.
DR   PDB; 8TQO; EM; 3.10 A; E=1-523.
DR   PDB; 8TQZ; EM; 2.90 A; E/F=1-523.
DR   PDBsum; 6CAJ; -.
DR   PDBsum; 6EZO; -.
DR   PDBsum; 6K71; -.
DR   PDBsum; 6K72; -.
DR   PDBsum; 6O81; -.
DR   PDBsum; 6O85; -.
DR   PDBsum; 6O9Z; -.
DR   PDBsum; 7D43; -.
DR   PDBsum; 7D44; -.
DR   PDBsum; 7D45; -.
DR   PDBsum; 7D46; -.
DR   PDBsum; 7F64; -.
DR   PDBsum; 7F66; -.
DR   PDBsum; 7F67; -.
DR   PDBsum; 7KMF; -.
DR   PDBsum; 7L70; -.
DR   PDBsum; 7L7G; -.
DR   PDBsum; 7RLO; -.
DR   PDBsum; 7TRJ; -.
DR   PDBsum; 7VLK; -.
DR   PDBsum; 8TQO; -.
DR   PDBsum; 8TQZ; -.
DR   AlphaFoldDB; Q9UI10; -.
DR   EMDB; EMD-0649; -.
DR   EMDB; EMD-0651; -.
DR   EMDB; EMD-0664; -.
DR   EMDB; EMD-22924; -.
DR   EMDB; EMD-23209; -.
DR   EMDB; EMD-24535; -.
DR   EMDB; EMD-26098; -.
DR   EMDB; EMD-30568; -.
DR   EMDB; EMD-30569; -.
DR   EMDB; EMD-30570; -.
DR   EMDB; EMD-30571; -.
DR   EMDB; EMD-31472; -.
DR   EMDB; EMD-31474; -.
DR   EMDB; EMD-31475; -.
DR   EMDB; EMD-32023; -.
DR   EMDB; EMD-41510; -.
DR   EMDB; EMD-41566; -.
DR   EMDB; EMD-4162; -.
DR   EMDB; EMD-7442; -.
DR   EMDB; EMD-9840; -.
DR   EMDB; EMD-9841; -.
DR   EMDB; EMD-9842; -.
DR   SMR; Q9UI10; -.
DR   BioGRID; 114407; 153.
DR   ComplexPortal; CPX-8343; Eukaryotic translation initiation factor 2B complex.
DR   CORUM; Q9UI10; -.
DR   FunCoup; Q9UI10; 3234.
DR   IntAct; Q9UI10; 101.
DR   MINT; Q9UI10; -.
DR   STRING; 9606.ENSP00000429323; -.
DR   GlyGen; Q9UI10; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UI10; -.
DR   PhosphoSitePlus; Q9UI10; -.
DR   SwissPalm; Q9UI10; -.
DR   BioMuta; EIF2B4; -.
DR   DMDM; 28381357; -.
DR   jPOST; Q9UI10; -.
DR   MassIVE; Q9UI10; -.
DR   PaxDb; 9606-ENSP00000394869; -.
DR   PeptideAtlas; Q9UI10; -.
DR   ProteomicsDB; 84448; -. [Q9UI10-1]
DR   ProteomicsDB; 84449; -. [Q9UI10-2]
DR   ProteomicsDB; 84450; -. [Q9UI10-3]
DR   Pumba; Q9UI10; -.
DR   Antibodypedia; 47347; 193 antibodies from 31 providers.
DR   DNASU; 8890; -.
DR   Ensembl; ENST00000347454.9; ENSP00000233552.6; ENSG00000115211.17. [Q9UI10-1]
DR   Ensembl; ENST00000445933.6; ENSP00000394397.2; ENSG00000115211.17. [Q9UI10-3]
DR   Ensembl; ENST00000451130.6; ENSP00000394869.2; ENSG00000115211.17. [Q9UI10-2]
DR   GeneID; 8890; -.
DR   KEGG; hsa:8890; -.
DR   MANE-Select; ENST00000347454.9; ENSP00000233552.6; NM_001034116.2; NP_001029288.1.
DR   UCSC; uc002rjz.4; human. [Q9UI10-1]
DR   AGR; HGNC:3260; -.
DR   CTD; 8890; -.
DR   DisGeNET; 8890; -.
DR   GeneCards; EIF2B4; -.
DR   GeneReviews; EIF2B4; -.
DR   HGNC; HGNC:3260; EIF2B4.
DR   HPA; ENSG00000115211; Low tissue specificity.
DR   MalaCards; EIF2B4; -.
DR   MIM; 606687; gene.
DR   MIM; 620314; phenotype.
DR   neXtProt; NX_Q9UI10; -.
DR   OpenTargets; ENSG00000115211; -.
DR   Orphanet; 157713; Congenital or early infantile CACH syndrome.
DR   Orphanet; 99854; Cree leukoencephalopathy.
DR   Orphanet; 157719; Juvenile or adult CACH syndrome.
DR   Orphanet; 157716; Late infantile CACH syndrome.
DR   Orphanet; 99853; Ovarioleukodystrophy.
DR   PharmGKB; PA27691; -.
DR   VEuPathDB; HostDB:ENSG00000115211; -.
DR   eggNOG; KOG1467; Eukaryota.
DR   GeneTree; ENSGT00550000075009; -.
DR   HOGENOM; CLU_016218_3_3_1; -.
DR   InParanoid; Q9UI10; -.
DR   OMA; MRDYVIC; -.
DR   OrthoDB; 10254737at2759; -.
DR   PAN-GO; Q9UI10; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9UI10; -.
DR   TreeFam; TF101508; -.
DR   PathwayCommons; Q9UI10; -.
DR   Reactome; R-HSA-72731; Recycling of eIF2:GDP.
DR   SignaLink; Q9UI10; -.
DR   SIGNOR; Q9UI10; -.
DR   BioGRID-ORCS; 8890; 830 hits in 1169 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   ChiTaRS; EIF2B4; human.
DR   GeneWiki; EIF2B4; -.
DR   GenomeRNAi; 8890; -.
DR   Pharos; Q9UI10; Tbio.
DR   PRO; PR:Q9UI10; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9UI10; protein.
DR   Bgee; ENSG00000115211; Expressed in lower esophagus mucosa and 203 other cell types or tissues.
DR   ExpressionAtlas; Q9UI10; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005851; C:eukaryotic translation initiation factor 2B complex; IDA:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0003743; F:translation initiation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0031369; F:translation initiation factor binding; ISS:UniProtKB.
DR   GO; GO:0002183; P:cytoplasmic translational initiation; IDA:UniProtKB.
DR   GO; GO:0042552; P:myelination; IMP:UniProtKB.
DR   GO; GO:0014003; P:oligodendrocyte development; IMP:UniProtKB.
DR   GO; GO:0001541; P:ovarian follicle development; IMP:UniProtKB.
DR   GO; GO:0006417; P:regulation of translation; NAS:UniProtKB.
DR   GO; GO:0009749; P:response to glucose; ISS:UniProtKB.
DR   GO; GO:0009408; P:response to heat; ISS:UniProtKB.
DR   GO; GO:0043434; P:response to peptide hormone; ISS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006413; P:translational initiation; IDA:UniProtKB.
DR   FunFam; 3.40.50.10470:FF:000002; Probable translation initiation factor eIF-2B subunit delta; 1.
DR   Gene3D; 3.40.50.10470; Translation initiation factor eif-2b, domain 2; 1.
DR   InterPro; IPR000649; IF-2B-related.
DR   InterPro; IPR042529; IF_2B-like_C.
DR   InterPro; IPR037171; NagB/RpiA_transferase-like.
DR   PANTHER; PTHR10233; TRANSLATION INITIATION FACTOR EIF-2B; 1.
DR   PANTHER; PTHR10233:SF14; TRANSLATION INITIATION FACTOR EIF-2B SUBUNIT DELTA; 1.
DR   Pfam; PF01008; IF-2B; 1.
DR   SUPFAM; SSF100950; NagB/RpiA/CoA transferase-like; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm;
KW   Disease variant; Initiation factor; Leukodystrophy; Phosphoprotein;
KW   Protein biosynthesis; Proteomics identification; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..523
FT                   /note="Translation initiation factor eIF2B subunit delta"
FT                   /id="PRO_0000156067"
FT   REGION          1..147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          170..179
FT                   /note="May bind the chemical integrated stress response
FT                   (ISR) inhibitor ISRIB"
FT                   /evidence="ECO:0000305|PubMed:25858979"
FT   COMPBIAS        30..40
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        41..51
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        87..121
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         86
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..10
FT                   /note="MAAVAVAVRE -> MPTQQPAAPSTRAPKPSRSLSGSLCALFSDA (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_001433"
FT   VAR_SEQ         71
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_040130"
FT   VARIANT         93
FT                   /note="A -> V (in dbSNP:rs34155621)"
FT                   /id="VAR_048918"
FT   VARIANT         209
FT                   /note="R -> Q (in VWM4; dbSNP:rs113994028)"
FT                   /evidence="ECO:0000269|PubMed:15776425"
FT                   /id="VAR_068455"
FT   VARIANT         228
FT                   /note="A -> V (in VWM4; dbSNP:rs113994027)"
FT                   /evidence="ECO:0000269|PubMed:11835386"
FT                   /id="VAR_015405"
FT   VARIANT         269
FT                   /note="L -> R (in VWM4; dbSNP:rs113994031)"
FT                   /evidence="ECO:0000269|PubMed:15776425"
FT                   /id="VAR_068456"
FT   VARIANT         306
FT                   /note="R -> G (in dbSNP:rs78599355)"
FT                   /evidence="ECO:0000269|PubMed:11835386"
FT                   /id="VAR_015406"
FT   VARIANT         357
FT                   /note="R -> Q (in VWM4; dbSNP:rs113994033)"
FT                   /evidence="ECO:0000269|PubMed:11835386"
FT                   /id="VAR_015407"
FT   VARIANT         374
FT                   /note="R -> C (in VWM4; dbSNP:rs113994035)"
FT                   /evidence="ECO:0000269|PubMed:11835386,
FT                   ECO:0000269|PubMed:15776425"
FT                   /id="VAR_015408"
FT   VARIANT         465
FT                   /note="C -> R (in VWM4; with ovarian failure;
FT                   dbSNP:rs113994038)"
FT                   /evidence="ECO:0000269|PubMed:12707859"
FT                   /id="VAR_016843"
FT   VARIANT         489
FT                   /note="Y -> H (in VWM4; with ovarian failure;
FT                   dbSNP:rs113994040)"
FT                   /evidence="ECO:0000269|PubMed:12707859"
FT                   /id="VAR_016844"
FT   CONFLICT        197
FT                   /note="S -> T (in Ref. 2;
FT                   CAB57260/CAB57261/CAB57304/CAB57305)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        323
FT                   /note="A -> S (in Ref. 1; AAF17195)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        481
FT                   /note="S -> L (in Ref. 1; AAF17195)"
FT                   /evidence="ECO:0000305"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:6CAJ"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:6CAJ"
FT   HELIX           192..195
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          201..203
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           205..215
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           222..239
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:7F66"
FT   HELIX           248..266
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           271..285
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:7RLO"
FT   HELIX           293..324
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          332..337
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           340..351
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          357..362
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   TURN            364..366
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           369..378
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          383..387
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           388..390
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           391..394
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           395..397
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          400..404
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          406..408
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          410..412
FT                   /evidence="ECO:0007829|PDB:6CAJ"
FT   STRAND          414..417
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           420..429
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          434..437
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           440..442
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           460..463
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          467..469
FT                   /evidence="ECO:0007829|PDB:6CAJ"
FT   TURN            472..475
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           476..478
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          482..484
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          489..492
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           494..496
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          499..502
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   STRAND          505..507
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           509..511
FT                   /evidence="ECO:0007829|PDB:7VLK"
FT   HELIX           512..520
FT                   /evidence="ECO:0007829|PDB:7VLK"
SQ   SEQUENCE   523 AA;  57557 MW;  5F38CF10CAD5A45E CRC64;
     MAAVAVAVRE DSGSGMKAEL PPGPGAVGRE MTKEEKLQLR KEKKQQKKKR KEEKGAEPET
     GSAVSAAQCQ VGPTRELPES GIQLGTPREK VPAGRSKAEL RAERRAKQEA ERALKQARKG
     EQGGPPPKAS PSTAGETPSG VKRLPEYPQV DDLLLRRLVK KPERQQVPTR KDYGSKVSLF
     SHLPQYSRQN SLTQFMSIPS SVIHPAMVRL GLQYSQGLVS GSNARCIALL RALQQVIQDY
     TTPPNEELSR DLVNKLKPYM SFLTQCRPLS ASMHNAIKFL NKEITSVGSS KREEEAKSEL
     RAAIDRYVQE KIVLAAQAIS RFAYQKISNG DVILVYGCSS LVSRILQEAW TEGRRFRVVV
     VDSRPWLEGR HTLRSLVHAG VPASYLLIPA ASYVLPEVSK VLLGAHALLA NGSVMSRVGT
     AQLALVARAH NVPVLVCCET YKFCERVQTD AFVSNELDDP DDLQCKRGEH VALANWQNHA
     SLRLLNLVYD VTPPELVDLV ITELGMIPCS SVPVVLRVKS SDQ
//
